We are live on ! Find out more
NC

nVerses Capital Portfolio holdings

AUM $65M
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$51.1M
Cap. Flow
+$41.9M
Cap. Flow %
19.19%
Top 10 Hldgs %
5.26%
Holding
1,446
New
467
Increased
322
Reduced
154
Closed
487

Top Buys

Rank Stock Value
1
EIX icon
Edison International
EIX
+$1.11M
2
ADM icon
Archer Daniels Midland
ADM
+$1.1M
3
NSC icon
Norfolk Southern
NSC
+$1.03M
4
PPL
PPL Corp
PPL
+$1.02M
5
PCG icon
PG&E
PCG
+$1.01M

Sector Composition

Rank Sector Weight
1 Technology 18.36%
2 Industrials 18.33%
3 Financials 14.86%
4 Consumer Discretionary 11.86%
5 Healthcare 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
851
Replimune Group
REPL
$1.22B
$14.2K 0.01%
+1,300
New +$13.2K
CABA icon
852
Cabaletta Bio
CABA
$336M
$14.2K 0.01%
+3,000
New +$17.4K
TLS icon
853
Telos
TLS
$302M
$14K 0.01%
+3,900
New +$13.9K
CRCT icon
854
Cricut
CRCT
$1.34B
$13.9K 0.01%
2,000
-4,600
-70% -$27.6K
AFYA icon
855
Afya
AFYA
$1.05B
$13.7K 0.01%
800
– –
ATRO icon
856
Astronics
ATRO
$2.9B
$13.6K 0.01%
840
-840
-50% -$14.3K
RZLT icon
857
Rezolute
RZLT
$396M
$13.6K 0.01%
+2,800
New +$12.9K
TPC
858
Tutor Perini Cor
TPC
$4.44B
$13.6K 0.01%
500
-2,400
-83% -$54.9K
TIGO icon
859
Millicom
TIGO
$15.4B
$13.6K 0.01%
+500
New +$12.9K
ARWR icon
860
Arrowhead Research
ARWR
$9.36B
$13.6K 0.01%
700
-3,000
-81% -$73.2K
MED icon
861
Medifast
MED
$130M
$13.4K 0.01%
700
-1,000
-59% -$19.3K
DCO icon
862
Ducommun
DCO
$2.58B
$13.2K 0.01%
+200
New +$12.5K
ACTG icon
863
Acacia Research
ACTG
$423M
$13K 0.01%
+2,800
New +$13.8K
MXL icon
864
MaxLinear
MXL
$8.41B
$13K 0.01%
+900
New +$14.3K
AAOI icon
865
Applied Optoelectronics
AAOI
$8.55B
$12.9K 0.01%
+900
New +$9.33K
HOUS
866
DELISTED
Anywhere Real Estate
HOUS
$12.7K 0.01%
2,500
-3,000
-55% -$13.9K
EBS icon
867
Emergent Biosolutions
EBS
$355M
$12.5K 0.01%
1,500
-1,100
-42% -$10K
ENTA icon
868
Enanta Pharmaceuticals
ENTA
$368M
$12.4K 0.01%
+1,200
New +$15.7K
FC icon
869
Franklin Covey
FC
$190M
$12.3K 0.01%
300
– –
FF icon
870
Future Fuel
FF
$222M
$12.1K 0.01%
2,100
-3,000
-59% -$16.7K
CHGG icon
871
Chegg
CHGG
$78.2M
$12K 0.01%
6,800
+800
+13% +$1.96K
IBEX icon
872
IBEX
IBEX
$576M
$12K 0.01%
+600
New +$10.3K
FMBH icon
873
First Mid Bancshares
FMBH
$1.3B
$11.7K 0.01%
300
+100
+50% +$3.78K
ZNTL icon
874
Zentalis Pharmaceuticals
ZNTL
$257M
$11.4K 0.01%
+3,100
New +$11.3K
ADVM
875
DELISTED
Adverum Biotechnologies
ADVM
$11.2K 0.01%
+1,600
New +$11.6K

Similar funds

nVerses Capital's Q3 2024 Portfolio in Review

As of Q3 2024, nVerses Capital held 1,446 positions worth $219M, up 31% from $167M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

nVerses Capital deployed $41.9M of net new capital in Q3 2024, opening 467 new positions and adding to 322 existing holdings. Its largest new stake was Edison International: 13,700 shares worth $1.19M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Insulet, an estimated $739K trimmed.

  • nVerses Capital's largest Q3 2024 buy was Edison International: 13,700 shares worth $1.19M.
  • nVerses Capital added most to Norfolk Southern in Q3 2024, an estimated $1.03M increase.
  • nVerses Capital's biggest Q3 2024 reduction was Insulet, cutting an estimated $739K.
  • nVerses Capital fully exited Huntington Bancshares in Q3 2024, selling an estimated $924K.
  • nVerses Capital's ten largest holdings make up 5.3% of its $219M portfolio in Q3 2024.
  • nVerses Capital opened 467 new positions and closed 487 in Q3 2024.
  • nVerses Capital's portfolio value rose 31% quarter-over-quarter to $219M.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.